NCT00317954View on ClinicalTrials.gov

Spironolactone in Diabetic Nephropathy

PHASE4CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

September 30, 2003

Study Completion Date

July 31, 2005

Conditions

Diabetic Nephropathy

Interventions

DRUG

Spironolactone

Trial Locations (1)

2820

Steno Diabetes Center, Gentofte Municipality

All Listed Sponsors

lead

Steno Diabetes Center Copenhagen

OTHER

NCT00317954 - Spironolactone in Diabetic Nephropathy | Biotech Hunter | Biotech Hunter